Harvard Heart Letter

New drug offers warfarin alternative for atrial fibrillation

A newly approved alternative to warfarin, a drug called dabigatran (sold under the brand name Pradaxa), fights stroke better than warfarin, with less bleeding into the brain, among people with atrial fibrillation. It could also make life a little bit easier for them. Pradaxa is not affected by diet and does not require its dosage to be fine-tuned. For some people, switching right away to Pradaxa makes sense. For others, it is worth adopting a watch-and-wait strategy. Talk with your doctor to see which approach is right for you.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »